International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries

BACKGROUND: Continuous androgen deprivation therapy (CADT) is commonly used for patients with non-metastatic prostate cancer as primary therapy for high-risk disease, adjuvant therapy together with radiation or for recurrence after initial local therapy. Intermittent ADT (IADT), a recently developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Liede, Alexander, Hallett, David C, Hope, Kirsty, Graham, Alex, Arellano, Jorge, Shahinian, Vahakn B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070274/
https://www.ncbi.nlm.nih.gov/pubmed/27843596
http://dx.doi.org/10.1136/esmoopen-2016-000040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070274/
https://www.ncbi.nlm.nih.gov/pubmed/27843596
http://dx.doi.org/10.1136/esmoopen-2016-000040

Ejemplares similares